The company

BioChange has developed a proprietary patented technology platform, capable of stimulating tissue and organs to regenerate naturally.

In 2017 we began our medical development, aiming initially for skin tissue regeneration with potential for applications such as soft tissue augmentation after tumor removal and aging reversal. We have achieved breakthrough pre-clinical results that prove our scaffold’s ability to stimulate tissue recovery, with notable vasculature of the newly formed tissue.

In our first phase, we developed and brought to market veterinary products that solve unmet problems of periodontal disease and urinary incontinence (commercially available). By remodeling the tissue with our scaffold, we achieved an unprecedented effect, which was recorded in veterinary clinical studies and published in the Journal of Frontiers in Veterinary Science and the Journal of Veterinary Internal Medicine.


We utilize science to increase human healthy lifespan, restoring body functions and tissues lost with age.

Meet the Team

Executive leadership

Ishay Attar, MSc, MBA

Founder, CEO & Chairman

Dr. Ofir Artzi, MD

Chief Medical Officer

Keren Sinik, PhD

VP Operations

Yuval Eitan, PhD

 VP Technologies and Bioprinting Innovation

Advisory board

Mauro Wjuniski

Expert in dermatology marketing

Michal Graff, MSc

CMC consultant

Rina Lev, PhD

Senior Clinical & Regulatory Expert, BioMedical Strategy

Dr. Eran Gefen, MD

Medical Director

Dr. Sonya Schneier, MD

Medical Director – Pulmonology
phone icon Whatsapp icon